A detailed history of Polar Capital Holdings PLC transactions in Merus N.V. stock. As of the latest transaction made, Polar Capital Holdings PLC holds 1,267,052 shares of MRUS stock, worth $59.8 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares
1,267,052
Holding current value
$59.8 Million
% of portfolio
0.46%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$39.81 - $60.2 $50.4 Million - $76.3 Million
1,267,052 New
1,267,052 $75 Million
Q3 2023

Nov 14, 2023

SELL
$20.13 - $27.29 $5.03 Million - $6.82 Million
-250,000 Reduced 33.33%
500,000 $11.8 Million
Q1 2023

Dec 13, 2023

BUY
$14.25 - $20.5 $3.56 Million - $5.13 Million
250,000 Added 50.0%
750,000 $13.8 Million
Q4 2022

Feb 14, 2023

BUY
$12.8 - $23.66 $3.2 Million - $5.92 Million
250,000 Added 50.0%
750,000 $11.6 Million
Q2 2022

Aug 15, 2022

BUY
$13.98 - $29.25 $6.99 Million - $14.6 Million
500,000 New
500,000 $11.3 Million

Others Institutions Holding MRUS

About Merus N.V.


  • Ticker MRUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,878,200
  • Market Cap $2.16B
  • Description
  • Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...
More about MRUS
Track This Portfolio

Track Polar Capital Holdings PLC Portfolio

Follow Polar Capital Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Polar Capital Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Polar Capital Holdings PLC with notifications on news.